ClinicalTrials.gov record
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
ClinicalTrials.gov ID: NCT00087490
Public ClinicalTrials.gov record NCT00087490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus
Study identification
- NCT ID
- NCT00087490
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 1,077 participants
Conditions and interventions
Interventions
- linezolid Drug
- vancomycin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2004
- Primary completion
- Jun 30, 2007
- Completion
- Jun 30, 2007
- Last update posted
- Aug 7, 2012
2004 – 2007
United States locations
- U.S. sites
- 76
- U.S. states
- 27
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Montgomery | Alabama | 36106 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85723 | — |
| Pfizer Investigational Site | Los Angeles | California | 90033 | — |
| Pfizer Investigational Site | Palm Springs | California | 92262 | — |
| Pfizer Investigational Site | Rancho Mirage | California | 92270 | — |
| Pfizer Investigational Site | San Pedro | California | 90732 | — |
| Pfizer Investigational Site | Santa Fe Springs | California | 90670 | — |
| Pfizer Investigational Site | Sylmar | California | 91342 | — |
| Pfizer Investigational Site | Torrance | California | 90502 | — |
| Pfizer Investigational Site | Torrance | California | 90503 | — |
| Pfizer Investigational Site | Torrance | California | 90509 | — |
| Pfizer Investigational Site | Denver | Colorado | 80205 | — |
| Pfizer Investigational Site | Denver | Colorado | 80218 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06102 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06106 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06510 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06515 | — |
| Pfizer Investigational Site | Atlantis | Florida | 33462 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Pensacola | Florida | 32501-6390 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30909 | — |
| Pfizer Investigational Site | Blue Ridge | Georgia | 30513 | — |
| Pfizer Investigational Site | Honolulu | Hawaii | 96813 | — |
| Pfizer Investigational Site | Honolulu | Hawaii | 96817 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | — |
| Pfizer Investigational Site | Decatur | Illinois | 62526 | — |
| Pfizer Investigational Site | Hines | Illinois | 60141 | — |
| Pfizer Investigational Site | Maywood | Illinois | 60153 | — |
| Pfizer Investigational Site | North Chicago | Illinois | 60064 | — |
| Pfizer Investigational Site | Northlake | Illinois | 60164 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62701 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62702 | — |
| Pfizer Investigational Site | Iowa City | Iowa | 52242 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202-1798 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40217 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40222 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70121 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21230 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21237 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02111 | — |
| Pfizer Investigational Site | West Roxbury | Massachusetts | 02132 | — |
| Pfizer Investigational Site | East Lansing | Michigan | 48824 | — |
| Pfizer Investigational Site | Lansing | Michigan | 48912 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55422-2998 | — |
| Pfizer Investigational Site | Mpls | Minnesota | 55422 | — |
| Pfizer Investigational Site | Saint Paul | Minnesota | 55101 | — |
| Pfizer Investigational Site | Butte | Montana | 59701 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 46851 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Somers Point | New Jersey | 08244 | — |
| Pfizer Investigational Site | Stony Brook | New York | 11794 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Akron | Ohio | 44304 | — |
| Pfizer Investigational Site | Akron | Ohio | 44309 | — |
| Pfizer Investigational Site | Akron | Ohio | 44310 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43214 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43215 | — |
| Pfizer Investigational Site | Toledo | Ohio | 43608 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19141 | — |
| Pfizer Investigational Site | West Reading | Pennsylvania | 19611 | — |
| Pfizer Investigational Site | Ducktown | Tennessee | 37326 | — |
| Pfizer Investigational Site | Jackson | Tennessee | 38301 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390-9016 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107 | — |
| Pfizer Investigational Site | Forth Worth | Texas | 76104 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | St. George | Utah | 84770 | — |
| Pfizer Investigational Site | St. George | Utah | 84790 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98431 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00087490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00087490 live on ClinicalTrials.gov.